Tag: labeling changes post-approval

What Are Post-Approval Commitments and When Are They Needed?

Posted on digi By digi

What Are Post-Approval Commitments and When Are They Needed? Understanding Post-Approval Commitments: When and Why They Arise Introduction: Regulatory Oversight Doesn’t End at Approval Gaining marketing authorization is a critical milestone in the lifecycle of a drug or biologic. However, it does not mark the end of regulatory scrutiny. Post-approval commitments (PACs)—which include post-marketing requirements…

Read More “What Are Post-Approval Commitments and When Are They Needed?” »

Post-Approval Commitments, Regulatory Submissions and Approvals

Labeling Requirements for Companion Diagnostics

Posted on digi By digi

Labeling Requirements for Companion Diagnostics Regulatory Guide to Labeling Companion Diagnostics Accurately and Compliantly Introduction: Why Labeling Matters for CDx Approvals Labeling for companion diagnostics (CDx) is more than just a product insert — it’s a critical regulatory document that links the diagnostic to its intended therapeutic product. Regulatory authorities such as the FDA, EMA,…

Read More “Labeling Requirements for Companion Diagnostics” »

Biomarkers and Companion Diagnostics, Regulatory Approval Pathways